Hospitalization among vaccines for SARS-CoV-2 breakthrough infection after dose sparing strategies in Libya: A cohort study

por Abdelhamid, Mohamed Hadi Mohamed, Almsellati, Iman Amin, Annajar, Badereddin B., Abdulhamid, Alaa.H, Alemam, Hafsa, Etikar, Mohammed
Publicado 2022

Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 or Post-Vaccination in Libyan Population: Comparison of Four Vaccines

por Ebrahim, Fawzi, Tabal, Salah, Lamami, Yosra, Alhudiri, Inas M., El Meshri, Salah Edin, Al Dwigen, Samira, Arfa, Ramadan, Alboeshi, Asma, Alemam, Hafsa A., Abuhtna, Fauzia, Altrhouni, Rabeeah, Milad, Mohamed B., Elgriw, Nada A., Ruaua, Mahmoud A., Abusrewil, Zakarya, Harroush, Warda, Jallul, Mwada, Ali, Fouziyah S., Eltaib, Farag, Elzagheid, Adam
Publicado 2022